asparagine and Thromboembolism

asparagine has been researched along with Thromboembolism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrahamsson, J; Albertsen, BK; Frandsen, TL; Grell, K; Heyman, M; Jónsson, ÓG; Lund, B; Schmiegelow, K; Vettenranta, K; Wolthers, BO	1

Trials

1 trial(s) available for asparagine and Thromboembolism

Article	Year
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 07-01, Volume: 37, Issue:19 Topics: Adolescent; Antineoplastic Agents; Asparaginase; Asparagine; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Infant; Male; Osteonecrosis; Pancreatitis; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Risk; Thromboembolism; Treatment Outcome	2019

Article

Year

Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 07-01, Volume: 37, Issue:19

Topics: Adolescent; Antineoplastic Agents; Asparaginase; Asparagine; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Infant; Male; Osteonecrosis; Pancreatitis; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Risk; Thromboembolism; Treatment Outcome

2019